Power Probe Group, Inc. v. Innova Electronics Corporation

District Court, D. Nevada·Decided October 25, 2023·No. 2:21-cv-00332·Unknown

Opinion

) Case No.: 2:21-cv-00332-GMN-EJY Plaintiff, ) vs. ) ORDER GRANTING PRELIMINARY ) INJUNCTION ) Defendant. ) ) Pending before the Court is Plaintiff Power Probe Group Inc.’s Motion for Preliminary Injunction, (ECF No. 36). Defendant Innova Electronics Corporation filed a Response, (ECF No. 54), to which Plaintiff filed a Reply, (ECF No. 57). For the reasons discussed below, the Court GRANTS Plaintiff’s Motion for Preliminary Injunction. This case arises from Defendant’s alleged infringement of United States Patent No. 7,184,899 (“the ‘899 Patent”). (Compl. ¶ 14). The ‘899 Patent teaches an “Energizable Electrical Test Device For Measuring Current and Resistance of an Electrical Circuit.” (See ‘899 Patent, Ex. 1 to Compl., ECF No. 1-2). Defendant offers a competing product for sale, the Innova PowerCheck #5420 (the “Accused Product”). Plaintiff alleges that the Accused Product practices at least each limitation of Claim One of the ‘899 Patent. (See generally Mot. Prelim. Inj. (“Mot. PI”), ECF No. 36); (Product Page – Innova PowerCheck, Ex. 5 to Decl. Christian JJ Paredis, Ph.D (“Paredis Decl.”), Ex. A to Mot. PI, ECF No. 37-5). Following briefing, the Court conducted a two-day hearing on Plaintiff’s Motion for Preliminary Injunction. (See Mins. Proceedings, ECF Nos. 93, 95). Based on the parties’ briefing and testimony, this Court denied the motion for failing to raise serious questions on the merits that the Accused Product performs “measurement of a plurality of parameters.” (Order Denying P.I., ECF No. 101). To prove a likelihood of success on the merits, Plaintiff must prove that the Accused Product measures continuity in addition to voltage. (Id. 9:18–23). Because this Court found that the Accused Product merely detects continuity, the Court determined that the Accused Product did not measure continuity. (Id. 9:18–10:2). On appeal, the Federal Circuit concluded that that the District Court “erred in construing ‘continuity’ as a parameter that is not measurable,” and vacated and remanded for further proceedings regarding whether Plaintiff met the requirements for a preliminary injunction. (Fed. Cir. Op. at 5, ECF No. 141). Following instruction from the Court on remand, the parties filed supplemental briefing. (See ECF Nos. 153, 154). “A plaintiff seeking a preliminary injunction must establish that he is likely to succeed on the merits, that he is likely to suffer irreparable harm in the absence of preliminary relief, that the balance of equities tips in his favor, and that an injunction is in the public interest.” Winter v. NRDC, Inc., 555 U.S. 7, 20, (2008). Injunctive relief is “an extraordinary remedy that may only be awarded upon a clear showing that the plaintiff is entitled to such relief.” Id. at 22. “[C]ourts must balance the competing claims of injury and must consider the effect on each party of the granting or withholding of the requested relief.” Id. at 24 (internal quotation marks omitted). The Ninth Circuit has held that “serious questions going to the merits and a hardship balance that tips sharply toward the plaintiff can support issuance of an injunction, assuming the other two elements of the Winter test are also met.” Alliance for the Wild Rockies v. Cottrell, 632 F.3d 1127, 1132 (9th Cir. 2011) (internal quotation marks omitted). ///

// “Courts have the power to grant injunctions to prevent the violation of patent rights.” Pfizer, Inc. v. Teva Pharms., USA, Inc., 429 F.3d 1364, 1372 (Fed. Cir. 2005) (citing 35 U.S.C. § 283 (2000)). “In considering whether to grant a preliminary injunction, a court must consider whether the patent owner has shown: (1) a reasonable likelihood of success on the merits; (2) the prospect of irreparable harm to the patent owner; (3) the balance of hardships tips in its favor; and (4) granting the injunction would not adversely affect the public interest.” Id. Before the Court can determine the patent holder’s likelihood of success on the merits, the Court must first make preliminary decisions on relevant disputed terms. Then, the Court will determine whether Plaintiff has sufficiently shown the four preliminary injunction factors. A. Preliminary Claim Construction “It is a bedrock principle of patent law that the claims of a patent define the invention to which the patentee is entitled the right to exclude.” Phillips v. AWH Corp., 415 F.3d 1303, 1312 (Fed. Cir. 2005) (en banc) (citations and internal quotation marks omitted). The interpretation of the scope and meaning of disputed terms in patent claims is a question of law and exclusively within the province of a court to decide. Markman v. Westview Instruments, Inc., 517 U.S. 370, 372 (1996). When construing disputed claim terms, the Court must give each disputed term “the meaning that the term would have to a person of ordinary skill in the art at the time of the invention,” unless the patentee clearly intended a different definition. Phillips v. AWH Corp., 415 F.3d 1303, 1312–13 (Fed. Cir. 2005). Furthermore, “the person of ordinary skill in the art is deemed to read the claim term not only in the context of the particular claim in which the disputed term appears but in the context of the entire patent, including the specification.” Id. at 1313. In certain cases, “the ordinary meaning of claim language as understood by a person of

Free access — add to your briefcase to read the full text and ask questions with AI

Power Probe Group, Inc. v. Innova Electronics Corporation, (D. Nev. 2023).

Power Probe Group, Inc. v. Innova Electronics Corporation (Power Probe Group, Inc. v. Innova Electronics Corporation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Junior Money Bags, Ltd. v. Segal
970 F.2d 1 (Fifth Circuit, 1992)
United Carbon Co. v. Binney & Smith Co.
317 U.S. 228 (Supreme Court, 1942)
Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.
535 U.S. 722 (Supreme Court, 2002)
ASTRAZENECA LP v. Apotex, Inc.
633 F.3d 1042 (Federal Circuit, 2010)
Titan Tire Corp. v. Case New Holland, Inc.
566 F.3d 1372 (Federal Circuit, 2009)
Sanofi-Synthelabo v. Apotex, Inc.
470 F.3d 1368 (Federal Circuit, 2006)
Pfizer, Inc. v. Teva Pharmaceuticals Usa, Inc.
429 F.3d 1364 (Federal Circuit, 2005)
Salazar v. Procter & Gamble Company
414 F.3d 1342 (Federal Circuit, 2005)
Hybritech Incorporated v. Monoclonal Antibodies, Inc.
802 F.2d 1367 (Federal Circuit, 1986)
Hybritech Incorporated v. Abbott Laboratories
849 F.2d 1446 (Federal Circuit, 1988)
Robert Bosch LLC v. Pylon Manufacturing Corp.
659 F.3d 1142 (Federal Circuit, 2011)
Celsis in Vitro, Inc. v. CellzDirect, Inc.
664 F.3d 922 (Federal Circuit, 2012)
Thorner v. Sony Computer Entertainment America LLC
669 F.3d 1362 (Federal Circuit, 2012)
F. Brantley Scott and John H. Burton v. Roy P. Finney
34 F.3d 1058 (Federal Circuit, 1994)